Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Emerging drugs for the treatment of gastrointestinal stromal tumors.
Pilco-Janeta DF, García-Valverde A, Gomez-Peregrina D, Serrano C. Pilco-Janeta DF, et al. Among authors: garcia valverde a. Expert Opin Emerg Drugs. 2021 Mar;26(1):53-62. doi: 10.1080/14728214.2021.1896704. Epub 2021 Mar 10. Expert Opin Emerg Drugs. 2021. PMID: 33645383 Review.
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?
Gómez-Peregrina D, García-Valverde A, Pilco-Janeta D, Serrano C. Gómez-Peregrina D, et al. Among authors: garcia valverde a. Curr Treat Options Oncol. 2021 Feb 27;22(4):32. doi: 10.1007/s11864-021-00832-5. Curr Treat Options Oncol. 2021. PMID: 33641024 Review.
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor.
García-Valverde A, Rosell J, Sayols S, Gómez-Peregrina D, Pilco-Janeta DF, Olivares-Rivas I, de Álava E, Maurel J, Rubió-Casadevall J, Esteve A, Gut M, Valverde C, Barretina J, Carles J, Demetri GD, Fletcher JA, Arribas J, Serrano C. García-Valverde A, et al. Oncogene. 2021 Dec;40(48):6614-6626. doi: 10.1038/s41388-021-02049-0. Epub 2021 Oct 7. Oncogene. 2021. PMID: 34621020
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
Serrano C, Vivancos A, López-Pousa A, Matito J, Mancuso FM, Valverde C, Quiroga S, Landolfi S, Castro S, Dopazo C, Sebio A, Virgili AC, Menso MM, Martín-Broto J, Sansó M, García-Valverde A, Rosell J, Fletcher JA, George S, Carles J, Arribas J. Serrano C, et al. Among authors: garcia valverde a. BMC Cancer. 2020 Feb 5;20(1):99. doi: 10.1186/s12885-020-6597-x. BMC Cancer. 2020. PMID: 32024476 Free PMC article.
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.
Serrano-Candelas E, Ainsua-Enrich E, Navinés-Ferrer A, Rodrigues P, García-Valverde A, Bazzocco S, Macaya I, Arribas J, Serrano C, Sayós J, Arango D, Martin M. Serrano-Candelas E, et al. Among authors: garcia valverde a. Mol Oncol. 2018 Aug;12(8):1383-1397. doi: 10.1002/1878-0261.12332. Epub 2018 Jun 30. Mol Oncol. 2018. PMID: 29885053 Free PMC article.
Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells.
Menendez-Gonzalez JB, Sinnadurai S, Gibbs A, Thomas LA, Konstantinou M, Garcia-Valverde A, Boyer M, Wang Z, Boyd AS, Blair A, Morgan RG, Rodrigues NP. Menendez-Gonzalez JB, et al. Among authors: garcia valverde a. Sci Rep. 2019 Aug 21;9(1):12212. doi: 10.1038/s41598-019-48589-0. Sci Rep. 2019. PMID: 31434974 Free PMC article.